Robert Bittman
17Patents
5h-index
20Co-inventors
66Inventor score
Filing activity: Feb 11, 1992 → Apr 24, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6676510B1 | Electronic gaming device having random reel mapping | Physics | 40 | Expired |
| US5369097A | Phosphonates as anti-cancer agents | Chemistry; Metallurgy | 22 | Expired |
| US5506217A | Phosphonates as anti-cancer agents | Chemistry; Metallurgy | 6 | Expired |
| US5219845A | Phosphonates as anti-inflammation agents | Chemistry; Metallurgy | 5 | Expired |
| US5837732A | Antimycobacterial compounds and method of using same | Chemistry; Metallurgy | 5 | Expired |
| US5756774A | Synthesis of myo-inositol phosphates | Chemistry; Metallurgy | 3 | Expired |
| US6153736A | Modified ether glyceroglycolipids | Human Necessities | 2 | Expired |
| US6573246B1 | Modified ether glyceroglycolipids | Human Necessities | 1 | Expired |
| US8277775B2 | Boron dipyrromethene difluoro (BODIPY) conjugates | Chemistry; Metallurgy | 1 | Active |
| US6613748B2 | C-glucosyl ether lipids | Human Necessities | 1 | Expired |
| US9359389B2 | Caged ceramide-1-phosphate derivatives | Chemistry; Metallurgy | 1 | Active |
| US8263576B2 | Non-natural sphingolipid analogs and uses thereof | Physics | 1 | Active |
| US8030482B2 | Free cholesterol analogs bearing a boron dipyrromethene difluoro (BODIPY) fluorophore in the side chain and method of preparation and use thereof | Chemistry; Metallurgy | 0 | Active |
| US7323601B2 | Enanitomers of unsaturated alkyllysophosphonocholines and use as anti-neoplastics | Chemistry; Metallurgy | 0 | Expired |
| US9133097B2 | Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US8153615B2 | Synthesis of glycerolipid carbamates and dicarbamates and their use as an antitumor compounds | Human Necessities | 0 | Active |
| US8741967B2 | Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.